Perceptions of French general practitioners and patients regarding dextropropoxyphene withdrawal: a qualitative study

OBJECTIVES: Dextropropoxyphene (DXP), a step 2 analgesic commonly prescribed in France, was withdrawn from the French market in 2011 following a European decision due to its poor risk-benefit ratio. The purpose of this study was to explore the perceptions of French general practitioners (GPs) and pa...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Open
Egile Nagusiak: Combier, Aurélie, Bon, Lucile, Van Ganse, Eric, Aubrun, Frédéric, Letrilliart, Laurent
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2018
Gaiak:
Health Services Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6157533/
https://ncbi.nlm.nih.gov/pubmed/30244207
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2018-021582
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak